处理 SSI 文件时出错
You are here: 生物谷 >> Conferences >> professional >> Infocontent Login Reg
Neurocrine Biosciences to Present at The Merrill Lynch Global Conference
Author:佚名    InfoSource:pharmalive.com    Hits:    Update Time:2006-2-10 Recommend

Live Audio Webcast Tuesday, February 7, 2006

SAN DIEGO, February 06, 2006 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc., a biopharmaceutical company focused on neurological and endocrine diseases and disorders announced today that Gary Lyons, President and CEO will present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference tomorrow, Tuesday, February 7, 2006 at the Grand Hyatt Hotel in New York.

The live presentation begins at 2:20 p.m. Eastern Time (ET) / 11:20 a.m. Pacific Time (PT) with an overview of the Company's development pipeline and research programs followed by an extended Q&A session. The presentation will be webcast and can be accessed on the Company's website at http://www.neurocrine.com.

A replay of the webcast will be available approximately 24 hours after the presentation concludes and will be archived until Tuesday, February 21, 2006. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at 858-617-7600 and ask for Claudia Woodworth or Elizabeth Foster.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical Company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com

CONTACT: Claudia Woodworth or Elizabeth Foster, both of NeurocrineBiosciences, Inc., +1-858-617-7600

Web site: http://www.neurocrine.com/

Ticker Symbol: (NASDAQ-NMS:NBIX)

Terms and conditions of use apply
Copyright © 2006 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


Search
 

  InfoInputer:admin    Editor:admin 
  • PrevarticleInfo:

  • NextarticleInfo:
  • Comment】【Add to Favorite】【Send Mail】【Print】【Close Window

    Relation news

  • Monotherapy phase I clinic

  • Bristol-Myers Squibb and O

  • Viragen reports on Multife

  • FDA grants fast track stat

  • Sanofi pasteur delivers mo

  • Psychiatric Disorders Conf

  • Patient Compliance Executi

  • Schering-Plough to Webcast

  • Angiotech Pharmaceuticals 

  • PDI, Inc. to Present at UB

  • Recommended